世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

セルライト治療市場規模、シェア&トレンド分析レポート:施術タイプ別(非侵襲、低侵襲、局所)、セルライトタイプ別(ソフトセルライト、ハードセルライト)、エンドユーザー別、地域別、およびセグメント予測、2022年~2030年


Cellulite Treatment Market Size, Share & Trends Analysis Report By Procedure Type (Non-invasive, Minimally Invasive, Topical), By Cellulite Type (Soft Cellulite, Hard Cellulite), By End-use, By Region, And Segment Forecasts, 2022 - 2030

セルライト治療市場の成長と傾向 Grand View Research, Inc.の新しいレポートによると、世界のセルライト治療市場規模は2030年までに34億米ドルに達すると予想され、2022年から2030年まで11.3%のCAGRで拡大す... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年8月19日 US$5,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
101 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

セルライト治療市場の成長と傾向

Grand View Research, Inc.の新しいレポートによると、世界のセルライト治療市場規模は2030年までに34億米ドルに達すると予想され、2022年から2030年まで11.3%のCAGRで拡大するとされています。市場の成長は、座りがちなライフスタイルや不適切な食事による肥満の有病率の増加、これらの技術の有効性と安全性の向上に起因していると考えられます。また、政府の支援策も業界の成長に寄与すると期待されています。例えば、米国食品医薬品局(FDA)は2016年、低侵襲性セルライト治療法であるCellfinaを認可しました。Science Directが発表した記事によると、セルライトは思春期以降の女性の約80%が罹患し、最も耐え難い美的合併症の1つであると認識されています。このような疾患の高い有病率は、関連する社会的圧力とともに、業界の需要を促進すると予想されます。

COVID-19の大流行により、市場全体で売上、収益、業務に大きな損失が生じ、各国を財政危機に追い込みました。保健当局は、すべての美容クリニックに対して、緊急の場合を除き、患者の診察と治療を直ちに停止するよう命じ、その結果、オフィスが閉鎖され、業界全体で前例のない収益減少に見舞われました。2020年末になると、美容整形に対する需要が高まり、美容クリニックは有利な成長を遂げるようになりました。多くの美容外科医は、パンデミック時だけでなく、パンデミック後の状況においても、デジタルアプリケーションを介したオンライン診察を開始しました。

さらに、業界プレーヤーによって行われた新製品開発のイニシアチブは、業界の成長を後押しすることが期待されています。例えば、Endo International Plcは、Soliton, Inc.がセルライト治療のための非侵襲的治療のための臨床試験を開始した一方で、2020年末までにそのセルライト治療を起動すると予想されています。同市場は、予測期間中に大規模なM&Aや戦略的提携を目撃すると予想されています。これは、競合他社との競争を制限するために、既存のプレーヤーが市場統合に重点を置いていることに起因しています。例えば、インベスターズビジネスデイリー社の記事によると、アラガンは、エンドのセルライト治療の国際マーケティングのためのエンド-インターナショナルとのコラボレーションを模索すると推定されています。この提携は、Allerganのボディコントゥアリングとエステティックのポートフォリオを補完すると予想されます。

セルライト治療市場レポートハイライト

- 非侵襲的な処置のタイプが2021年に最大の収益シェアを占めました。これは、これらの処置の高い可用性に起因することができる

- ソフトセルライトタイプセグメントは、予測期間中に有利な成長を目撃すると予想されます。簡単な除去プロセスと一緒にこのセルライトタイプの高い有病率は、市場の需要に燃料を供給することが予想される

- クリニックとビューティーセンターのエンドユーズセグメントは、2021年に市場をリードし、予測期間中に急速に成長すると推定されています。

- 2021年に北米が主要地域として浮上しました。これは、高度な医療インフラの存在、熟練した人材の存在、同地域の化粧品および美容処置への比較的高い支出に起因することができる


ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cellulite Treatment Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. Regulatory Framework
3.5.1. Reimbursement framework
3.5.2. Standards & Compliances
3.6. Market Dynamics
3.6.1. Market Driver Analysis
3.6.1.1. Growing prevalence of obesity
3.6.2. Market Restraint Analysis
3.6.2.1. High Cost
3.6.3. Industry Challenges
3.7. Cellulite Treatment: Market Analysis Tools
3.7.1. Industry Analysis - Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from new entrant
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Legal Landscape
3.7.3. Major Deals & Strategic Alliances Analysis
3.7.3.1. Joint Ventures
3.7.3.2. Mergers & Acquisitions
3.7.3.3. Licensing & Partnership
3.7.3.4. Technology Collaborations
3.7.3.5. Strategic Divestments
3.7.3.6. Market Entry Strategies
Chapter 4. Cellulite Treatment Market: Segment Analysis, By Procedure Type, 2018 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure type market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Cellulite Treatment Market, By Procedure Type, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Non-invasive
4.5.2. Minimally invasive
4.5.3. Topical
Chapter 5. Cellulite Treatment Market: Segment Analysis, By Cellulite Type, 2018 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Cellulite type market share analysis, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Cellulite Treatment Market, By Cellulite Type, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Soft cellulite
5.5.2. Hard cellulite
5.5.3. Edematous Cellulite
Chapter 6. Cellulite Treatment Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Cellulite Treatment Market, By End-use, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.2. Clinics & Beauty Centers
Chapter 7. Cellulite Treatment Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2021 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2021
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2022 to 2030:
7.8. North America
7.8.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.8.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8.2. U.S.
7.8.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8.3. Canada
7.8.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9. Europe
7.9.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.9.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.2. Germany
7.9.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.3. U.K.
7.9.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.4. France
7.9.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.5. Italy
7.9.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.6. Spain
7.9.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10. Asia Pacific
7.10.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.10.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.7. Australia
7.10.7.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.7.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11. Latin America
7.11.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.11.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.2. Brazil
7.11.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.3. Mexico
7.11.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.4. Argentina
7.11.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12. Middle East and Africa
7.12.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.12.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.2. South Africa
7.12.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.3. Saudi Arabia
7.12.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.4. UAE
7.12.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Chapter 8. Cellulite Treatment Market - Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4. Supplier Ranking
8.5. Key companies profiled
8.5.1. Merz Pharma.
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Hologic, Inc. (Cynosure)
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Syneron Medical
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Zimmer Aesthetics.
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Tanceuticals, LLC
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Cymedics.
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Nubway
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives

 

ページTOPに戻る


 

Summary

Cellulite Treatment Market Growth & Trends

The global cellulite treatment market size is anticipated to reach USD 3.4 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.3% from 2022 to 2030. The market growth can be attributed to the increasing prevalence of obesity due to sedentary lifestyles and improper diet and improved efficacy and safety of these techniques. In addition, supportive government initiatives are expected to contribute to industry growth. For instance, the U.S. Food and Drug Administration (FDA) cleared Cellfina, a minimally invasive cellulite treatment, in 2016. According to an article published by Science Direct, cellulite affects nearly 80% of post-pubertal women and is perceived to be one of the most intolerable aesthetic complications. Such a high prevalence of the disease along with the associated social pressure is anticipated to fuel the industry demand.

The COVID-19 pandemic resulted in major losses across markets in terms of sales, revenues, and operations, pushing countries into financial crises. Health authorities ordered all aesthetic clinics to immediately stop seeing and treating patients, except in emergencies, resulting in office closures and unprecedented revenue decline across the sector. By the end of 2020, aesthetic clinics started witnessing lucrative growth as the demand for cosmetic procedures increased. Many cosmetic surgeons started online consultations during the pandemic as well as post-pandemic landscape via digital applications.

Furthermore, new product development initiatives undertaken by the industry players are anticipated to boost industry growth. For instance, Endo International Plc is anticipated to launch its cellulite treatment by the end of 2020 while Soliton, Inc. has initiated clinical trials for its non-invasive treatment for cellulite treatment. The market is anticipated to witness significant mergers & acquisitions and strategic collaborations during the forecast period. This can be attributed to the emphasis on market consolidation by established players to limit competitive rivalry. For instance, according to an article by Investor's Business Daily, Inc., Allergan is estimated to seek collaboration with Endo International for international marketing of Endo’s cellulite treatment. This collaboration is anticipated to complement the body contouring and aesthetic portfolio of Allergan.

Cellulite Treatment Market Report Highlights

• Non-invasive procedure type held the largest revenue share in 2021. This can be attributed to the high availability of these procedures

• The soft cellulite type segment is anticipated to witness lucrative growth over the forecast period. The high prevalence of this cellulite type along with the easy removal process is anticipated to fuel the market demand

• The clinics and beauty centers end-use segment led the market in 2021 and is estimated to grow rapidly over the forecast period

• North America emerged as the leading region in 2021. This can be attributed to the presence of advanced medical infrastructure, presence of skilled personnel, and comparatively higher expenditure on cosmetic and aesthetic procedures in the region



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cellulite Treatment Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. Regulatory Framework
3.5.1. Reimbursement framework
3.5.2. Standards & Compliances
3.6. Market Dynamics
3.6.1. Market Driver Analysis
3.6.1.1. Growing prevalence of obesity
3.6.2. Market Restraint Analysis
3.6.2.1. High Cost
3.6.3. Industry Challenges
3.7. Cellulite Treatment: Market Analysis Tools
3.7.1. Industry Analysis - Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from new entrant
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Legal Landscape
3.7.3. Major Deals & Strategic Alliances Analysis
3.7.3.1. Joint Ventures
3.7.3.2. Mergers & Acquisitions
3.7.3.3. Licensing & Partnership
3.7.3.4. Technology Collaborations
3.7.3.5. Strategic Divestments
3.7.3.6. Market Entry Strategies
Chapter 4. Cellulite Treatment Market: Segment Analysis, By Procedure Type, 2018 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure type market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Cellulite Treatment Market, By Procedure Type, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Non-invasive
4.5.2. Minimally invasive
4.5.3. Topical
Chapter 5. Cellulite Treatment Market: Segment Analysis, By Cellulite Type, 2018 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Cellulite type market share analysis, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Cellulite Treatment Market, By Cellulite Type, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Soft cellulite
5.5.2. Hard cellulite
5.5.3. Edematous Cellulite
Chapter 6. Cellulite Treatment Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Cellulite Treatment Market, By End-use, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.2. Clinics & Beauty Centers
Chapter 7. Cellulite Treatment Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2021 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2021
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2022 to 2030:
7.8. North America
7.8.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.8.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8.2. U.S.
7.8.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.8.3. Canada
7.8.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.8.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.8.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9. Europe
7.9.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.9.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.2. Germany
7.9.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.3. U.K.
7.9.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.4. France
7.9.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.5. Italy
7.9.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.9.6. Spain
7.9.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.9.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.9.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10. Asia Pacific
7.10.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.10.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.5.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.6.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.10.7. Australia
7.10.7.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.10.7.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.10.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11. Latin America
7.11.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.11.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.2. Brazil
7.11.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.3. Mexico
7.11.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.11.4. Argentina
7.11.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.11.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.11.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12. Middle East and Africa
7.12.1.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
7.12.1.2. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.1.3. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.1.4. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.2. South Africa
7.12.2.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.2.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.2.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.3. Saudi Arabia
7.12.3.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.3.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.3.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
7.12.4. UAE
7.12.4.1. Market estimates and forecast, by procedure type, 2018 - 2030 (USD Million)
7.12.4.2. Market estimates and forecast, by cellulite type, 2018 - 2030 (USD Million)
7.12.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Chapter 8. Cellulite Treatment Market - Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4. Supplier Ranking
8.5. Key companies profiled
8.5.1. Merz Pharma.
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Hologic, Inc. (Cynosure)
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Syneron Medical
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Zimmer Aesthetics.
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Tanceuticals, LLC
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Cymedics.
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Nubway
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Grand View Research社のその他分野での最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る